Results 21 to 30 of about 100 (92)

Características obstétricas de mulheres atendidas por pré-eclâmpsia e eclâmpsia = Obstetric characteristics of women treated for pre-eclampsia and eclampsia

open access: yesActa Scientiarum. Health Sciences, 2011
Objetivou-se descrever as características da clientela com pré-eclâmpsia/eclâmpsia no período de 2007. A pesquisa, quantitativa, descritiva e documental foi realizada em um hospital municipal de Fortaleza, Estado do Ceará com serviço de emergência ...
Ione Cavalcante Lacerda   +1 more
doaj  

Enfermedad cardiovascular en el embarazo

open access: yesAteneo
La cardiopatía, es la principal causa de mortalidad no obstétrica durante el embarazo. El 29 % de pacientes con cardiopatía congénita, experimenta complicaciones cardiovasculares durante el embarazo o el posparto.   Objetivos: Determinar el manejo
Gabriel León San Miguel   +4 more
doaj  

Clinical practice guideline for the prevention and management of hypertensive disorders of pregnancy [PDF]

open access: yesRev Colomb Obstet Ginecol, 2022
Yanque-Robles O   +11 more
europepmc   +1 more source

Valvular Heart Disease Emergencies: A Comprehensive Review Focusing on the Initial Approach in the Emergency Department. [PDF]

open access: yesArq Bras Cardiol, 2023
Accorsi TAD   +8 more
europepmc   +1 more source

HIDRALAZINA, ÁCIDO VALPROICO E INTERFERON-y INCREMENTAN LA EXPRESIÓN DE MOLÉCULAS DE RECONOCIMIENTO INMUNE EN CÉLULAS TUMORALES DE CÁNCER CÉRVICO-UTERINO

open access: yes, 2009
""
R García Rocha   +4 more
openaire   +1 more source

SARS-CoV-2 and Myocardical Injury with ST-Elevation without Coronary Disease. [PDF]

open access: yesArq Bras Cardiol, 2021
Ragonetti C   +5 more
europepmc   +1 more source

Quimio y radiosensibilización con metronidazol, AK - 2123 y melfalan en el cáncer de mama T3-T4. Rol de la hidralazina resultados a 5 años

open access: yes, 1995
From 1988-1990, 32 women with Stage Ill, locally advanced breast cancer (LABC), eight (25%) with supraclavicular involvement, were treated with Metronidazol (MIZ) eight (25%) Patients, thirteen (41%) with the A-3 nitrotriazole (AK- 2123) and eleven (34%) were control ones. Median follow-up was 66 months. Three phases of the clinical trial evolved, each
Instituto Peruano de Seguridad Social   +3 more
openaire   +1 more source

[¿Cómo tratar la hipertensión arterial sistémica? Estrategias de tratamiento actuales]. [PDF]

open access: yesArch Cardiol Mex, 2021
Gopar-Nieto R   +4 more
europepmc   +1 more source

Prevalence of arterial hypertension in pediatric hospitalized patients. [PDF]

open access: yesArch Cardiol Mex, 2023
Chacón-Jaimes DC   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy